Carcinogenesis and Mutagenesis
A mutagen is a substance or agent that induces a heritable change in cells or organisms. A carcinogen is a substance that induces unregulated growth processes in cells or tissues of multicellular animals, leading to the disease called cancer. Mutagenesis refers to processes that result in genetic change, and carcinogenesis (the processes of tumor development) may result from mutagenic events. Carcinogenesis is a process where uncontrolled cell division occurs leading to the formation of a malignant tumor. Mutagenesis is a process characterized by a change in the genetic material of an organism by the influence of mutagens. Mutagenesis can occur naturally and leads to cancer.
Related Conference of Carcinogenesis and Mutagenesis
8th International Conference on Global Toxicology and Risk Assessment
7th International Conference on Clinical Pharmacology and Toxicology
Carcinogenesis and Mutagenesis Conference Speakers
Recommended Sessions
- Agricultural Toxicology
- Bioaccumulation & Ecology Impacts
- Carcinogenesis and Mutagenesis
- Climate Change
- Economic Toxicology
- Environmental Compliance
- Environmental Health and Safety
- Environmental Toxicology and Chemistry
- Epidemiology and Biostatistics
- Global Warming
- Green Chemistry
- Health Economics and Public Policies
- Medical Toxicology
- Occupational Toxicology
- Pollution
- Regulatory Toxicology
- Waste Recycling and Management
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Alternative Testing Methods and 3Rs in Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Carcinogenic Risk and Chemical-Induced Cancers - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Chemical Risk Assessment Frameworks - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Climate Change and Toxicological Risk - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Computational Toxicology and AI Applications - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Ecotoxicology and Aquatic System Contamination - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Endocrine Disrupting Chemicals and Public Health - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Environmental Toxicology and Ecosystem Impact - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Food Safety and Chemical Contaminants - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Forensic Toxicology and Chemical Poisoning - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Genetic Toxicology and DNA Damage Assessment - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Global Trends in Toxicology Research and Innovation - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Heavy Metals and Toxic Element Exposure - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Human Biomonitoring and Exposure Science - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Immunotoxicology and Hypersensitivity Reactions - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Industrial and Occupational Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Nanotoxicology and Engineered Nanomaterials - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neurotoxicology and Developmental Exposure - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pesticide Toxicology and Risk Management - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pharmaceutical Toxicology and Drug Safety - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Regulatory Toxicology and Global Policy Trends - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Risk Communication in Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicity of Consumer Products and Personal Care Items - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicogenomics and Systems Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicokinetics and Chemical Fate in the Body - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)